Skip to main content
  • Characteristics and Outcomes of Patients with Intraventricular Glioblastoma: a population-based analysis

    Final Number:
    1493

    Authors:
    Terence Verla; Ranjith Babu MD, MS; Vijay Agarwal MD; Allan H. Friedman MD; D. Cory Adamson MD PhD MPH MHSc

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2014 Annual Meeting

    Introduction: Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and may occur anywhere in the central nervous system. Tumor location significantly influences patient outcomes, with survival generally varying between supratentorial, brainstem, and spinal cord GBMs. Interestingly, there is little data on the outcomes of patients with intraventricular GBMs. The occurrence of GBMs within the ventricular system is exceptionally rare. The description of these tumors is currently limited to case reports and small case series, precluding an understanding of their natural history and prognostic factors. In this study, we have performed a population-based analysis of patients with intraventricular GBMs to characterize patient outcomes and evaluate the efficacy of surgical resection and radiotherapy.

    Methods: The Surveillance, Epidemiology, and End Results (SEER) database was utilized to identify adult patients with intraventricular GBMs. Patient, tumor, and treatment characteristics were summarized and analyzed to identify prognostic factors for survival.

    Results: A total of 162 patients met the inclusion criteria. The median age was 57 years, with males accounting for 66.7% of patients. The median tumor size was 4.3 centimeters. The majority of patients underwent surgical resection (60.5%) and radiotherapy (57.4%). The median overall survival for all patients was 5 months and was significantly lower than the survival of those with intraparenchymal supratentorial tumors (8 months; p=0.0047). Univariate analysis revealed age greater than 40 years (4 vs. 9 months, p=0.0008), radiotherapy (9 vs. 2 months, p<0.0001), and surgical resection (8 vs. 3 months, p=0.005) to significantly affect survival. On multivariate analysis, only age greater than 40 years (HR: 2.20;95%CI:1.37-4.53;p=0.0011) and radiotherapy (HR:0.31;95%CI:0.21-0.46;p<0.0001) were independent prognostic factors.

    Conclusions: Patients with intraventricular GBMs have a poor prognosis which is significantly worse than those with supratentorial tumors. While older age confers a worse survival, radiotherapy provides a significant survival benefit.

    Patient Care: While older age confers a worse survival, radiotherapy provides a significant survival benefit.

    Learning Objectives: Patients with intraventricular GBMs have a poor prognosis which is significantly worse than those with supratentorial tumors.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy